Faydra I Lieveld
Overview
Explore the profile of Faydra I Lieveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Patmore L, van Eekhout K, Buti M, Koc O, Agarwal K, de Knegt R, et al.
J Hepatol
. 2023 Oct;
80(2):243-250.
PMID: 37898348
Background & Aims: Sub-Saharan African (SSA) ethnicity has been associated with a higher risk of hepatocellular carcinoma (HCC) among individuals with chronic hepatitis B in cross-sectional studies. However, the incidence...
2.
van Welzen B, Smit C, Boyd A, Lieveld F, Mudrikova T, Reiss P, et al.
Open Forum Infect Dis
. 2020 Jul;
7(7):ofaa226.
PMID: 32665961
Background: The development of efficacious combination antiretroviral therapy (cART) has led to a dramatic decrease in mortality in HIV-positive patients. Specific data on the impact in HIV/hepatitis B virus (HBV)-coinfected...
3.
Lieveld F, Smit C, Richter C, van Erpecum K, Spanier B, Gisolf E, et al.
Liver Int
. 2018 Nov;
39(3):470-483.
PMID: 30411848
Background & Aims: HIV/hepatitis B virus (HBV) coinfected subjects are thought to have faster progression to end-stage liver disease (ESLD) than HBV mono-infected subjects. We assessed whether this remains in...
4.
Leoni M, Amelung L, Lieveld F, van den Brink J, de Bruijne J, Arends J, et al.
Clin Res Hepatol Gastroenterol
. 2018 Sep;
43(1):37-44.
PMID: 30219692
Background: Ursodeoxycholic acid (UDCA) is used for treatment of cholestatic liver diseases and may improve long-term outcome. Although treatment with this hydrophilic bile acid is virtually without side effects, medication...
5.
Kracht P, Lieveld F, Amelung L, Verstraete C, Mauser-Bunschoten E, de Bruijne J, et al.
Infect Dis Ther
. 2018 Aug;
7(3):373-385.
PMID: 30076582
Introduction: Pegylated interferon-based therapy for hepatitis C virus (HCV) negatively impacts nutritional state and patient-reported outcomes (PROs) such as health-related quality of life (HRQL). Clinical trials with direct-acting antivirals (DAAs)...
6.
Arends J, Lieveld F, Ahmad S, Ustianowski A
Infect Dis Ther
. 2017 Oct;
6(4):461-476.
PMID: 29071665
Although current therapies can be successful at suppressing hepatitis B viral load, long-term viral cure is not within reach. Subsequent strategies combining pegylated interferon alfa with nucleoside/nucleotide analogues have not...
7.
Lieveld F, Arends J, Amelung L, Dijk E, Gisolf E, Vrolijk J, et al.
Clin Infect Dis
. 2016 Dec;
64(2):233-235.
PMID: 27989987
No abstract available.
8.
Newsum A, Ho C, Lieveld F, van de Laar T, Koekkoek S, Rebers S, et al.
AIDS
. 2016 Nov;
31(1):105-112.
PMID: 27898592
Objectives: The Q80K polymorphism is a naturally occurring resistance-associated variant in the hepatitis C virus (HCV) nonstructural protein 3 (NS3) region and is likely transmissible between hosts. This study describes...
9.
Lieveld F, Swaans N, Newsum A, Ho C, Schinkel J, Molenkamp R, et al.
Ann Hepatol
. 2016 Aug;
15(5):696-704.
PMID: 27493108
Unlabelled: Background and aim. Resistance-associated variants (RAVs) on the NS3 region of the hepatitis C virus (HCV) may be relevant for antiviral therapy, but data in human immunodeficiency virus (HIV)...
10.
van Vlerken L, Lieveld F, van Meer S, Koek G, van Nieuwkerk K, Friederich P, et al.
Clin Res Hepatol Gastroenterol
. 2016 Feb;
40(5):622-630.
PMID: 26867863
Background And Objective: Adherence is essential in antiviral therapy for chronic hepatitis C. We investigated the effect of real-time medication monitoring on adherence to ribavirin. Methods: In this randomized controlled...